Healthwell Acquisition Corp. I (Nasdaq: HWEL) announced on Friday evening that its former target Starton has terminated its business combination.
Although the parties did not provide extensive detail regarding the termination, they clarified that the deal fell through due to certain closing conditions not being satisfied by the outside date of November 3.
Healthwell I unveiled its $339 million combination with Starton earlier this year in April. While the two sides initially agreed on a $15 million closing condition, they later reduced this to $10 million in September.
The SPAC brought about $253.7 million into the deal through its trust, but following redemptions from previous votes, it was left with around $41.8 million. Despite the expectation of supplementing this with $15 million from a PIPE or a debt facility, there has been no confirmation of securing this funding.
Paramus, New Jersey-based Starton is developing a line of treatments to improve efficacies in delivering drugs for certain types of cancer and mitigating the side effects of chemotherapy. Going forward, Starton will continue its clinical efforts to meet the completion of its study for the advancement of its patients.
As a result of this termination, Healthwell I will seek an alternative business combination. With a completion deadline of December 5, it currently has just a month to find a suitable target to combine with. However, it recently filed a proxy to hold a shareholder meeting aimed at extending this deadline until August 2024, granting them a nine-month window to finalize a deal.
Iron Horse Acquisitions Corp. II has filed for a $250 million SPAC with D. Boral Capital underwriting under its new name. D. Boral emerged in November from a messy dispute at the top of investment bank EF Hutton that was concluded with Joseph Rallo taking the EF Hutton trademark and departing the firm while David...
At the SPAC of Dawn This shortened trading week could be a rocky one as the market takes in the first wave of initiatives out of the new US administration and will have what are technically the first Trump 2.0 jobs numbers released on Thursday. It should be somewhat quieter for SPACs working through their...
Terms Tracker for the Week Ending January 17, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We may be heading into a Polar Vortex, but SPACs managed to generate some heat this week with three more IPOs. For those keeping count,...
Giving internet users a place to chat or post pictures of their lunch has never been an especially profitable endeavor until social media platforms gain the scale to leverage user data en masse like Meta (NASDAQ:META). But, the addition of retail investor appetites to the equation has suddenly turned even smaller platforms into a tantalizing...
At the SPAC of Dawn This week comes to a close with the debut of the year’s fourth SPAC IPO as Hennessy Capital Investment Corp. VII (NASDAQ:HVIIU) priced last night. This brings the month’s total IPO proceeds to $597.5 million, which is already a drastic year-on-year improvement from January 2023, which saw just $144 million...